H16.33
Sclerosing keratitis
Clinical Classification Guidelines
Medical Intelligence & Overview
Sclerosing keratitis is a rare eye condition characterized by the thickening and scarring of the cornea, the transparent front part of the eye. This condition can impair vision and lead to discomfort due to the changes in the cornea's structure. It is classified under ICD-10 code H16.33 and requires proper diagnosis and management by eye care professionals to prevent complications.
Causes & Symptoms
Clinical Causes: Chronic inflammation due to infections such as herpes simplex virus or bacterial keratitis Autoimmune diseases like rheumatoid arthritis or keratoconjunctivitis sicca Previous eye trauma or surgery leading to scarring and thickening Degenerative corneal conditions that progress over time Exposure to environmental irritants or prolonged ultraviolet light exposure
Key Symptoms: Gradual loss of vision or blurred vision Persistent eye discomfort or soreness A whitish or opaque appearance in parts of the cornea Sensitivity to light (photophobia) Redness and swelling of the affected eye A feeling of a foreign body in the eye Potential tearing or watery eyes
Diagnostic & Treatment
Diagnosis Path: Diagnosis of sclerosing keratitis involves a comprehensive eye examination by an ophthalmologist. The evaluation typically includes a slit-lamp exam to observe corneal changes, assessment of visual acuity, and possibly corneal imaging techniques such as anterior segment optical coherence tomography (AS-OCT). Additional tests might include corneal topography to assess the surface curvature and thickness, and laboratory investigations if an underlying autoimmune or infectious cause is suspected.
Treatment Protocols: Management of sclerosing keratitis aims to control inflammation, prevent progression, and restore as much vision as possible. Treatment options can vary based on the severity and cause of the condition and may include: - **Anti-inflammatory medications**: Topical corticosteroids or immunosuppressive drugs to reduce inflammation. - **Antibiotic or antiviral agents**: If an infectious cause is identified. - **Lubricating eye drops**: To soothe irritation and protect the cornea. - **Surgical intervention**: Procedures such as corneal transplantation may be considered in cases with extensive scarring and vision impairment. - **Addressing underlying causes**: Managing autoimmune diseases or treating environmental exposures to prevent further damage. Regular follow-up with an eye specialist is essential to monitor the condition and adjust treatment as needed.
Clinical Advice & FAQs
Billing Guidance
Is H16.33 a billable ICD-10 code?
Yes, H16.33 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H16.33?
Clinical documentation must specify the nature of Sclerosing keratitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference